Wenyun Yang - Health Insider

BTSDF -- USA Stock  

USD 7.49  0.00  0.00%

  Executive
Ms. Yang Wenyun is Joint Company Secretary of Biostime International Holdings Ltd. Ms. Yang works as the Director of the Listing Affairs and Risk Management Department, mainly in charge of overall listing affairs, legal affairs, administrative affairs and internal audit of the Group. She is also the supervisor of the Companys subsidiary Swisse Guangzhou. Ms. Yang started her professional career with the Group and has obtained substantial experience through corporate governance, risk management, administration, legal affairs, information security management, internal audit, public relations and human resources management over the past twelve years with the Group. From August 2005 to December 2008, she worked as an assistant of public affairs and was mainly responsible for the legal affairs and public relations of the Group. Concurrently, being an assistant to the general manager since November 2006, she was responsible for part of administrative affairs of the Group. From December 2008 to February 2010, she was promoted to be the legal manager of the Group and was responsible for the overall legal affairs and public relations. In February 2010, she assumed the responsibility of leading the risk control department. In January 2014, she was promoted from a senior manager to become the director of the department. From October 2015 to February 2017, Ms. Yang was temporarily responsible for human resources management as the director of Corporationrationrate Affairs and Human Resources Department
Age: 33  Executive Since 2010      
86 20 3818 9999  http://www.hh.global
Yang obtained a bachelor?s degree in law from Sun YatSen University in June 2005.

Management Efficiency

The company has return on total asset (ROA) of 8.91 % which means that it generated profit of $8.91 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 25.06 % meaning that it generated $25.06 on every $100 dollars invested by stockholders.
The company has accumulated 963 M in total debt with debt to equity ratio (D/E) of 150.3 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Health and Happiness International Holdings Limited has Current Ratio of 1.19 suggesting that it is in a questionable position to pay out its financial obligations in time and when they become due.

Similar Executives

Entity Summary

Health and Happiness International Holdings Limited, an investment holding company, manufactures and sells family nutrition and baby care products in Mainland China, Australia, New Zealand, and internationally. Health and Happiness International Holdings Limited is a subsidiary of Biostime Pharmaceuticals Limited. Health is traded on OTC Market in USA.Health and Happiness International Holdings Limited (BTSDF) is traded on OTC Market in USA. It is located in One Island East and employs 3,000 people.

Health and Happiness Leadership Team

Garnier Laetitia, International Cooperation Director
Xiaocheng Hu, Key Accounts Director and Director of National Supermarkets
Abel Benzakour, COO
Guanghua Chen, Director In Charge of Mama100 Membership Center
Fufang Chen, Non-Executive Director
Fangming Hu, Other
Huoyan Xiong, Promotion Director
Lixia He, Director of the brand project department of ?BMcare?
Wenyun Yang, Joint Company Secretary
Jun Yang, Director - Human Resources of the Group
Malard Patrice, CTO
Weifeng Wei, Non-Executive Independent Director
Zhenjie Xu, Human Resource Director
Yidong Wang, Chief Finance Officer
Wai Ngai, Non-Executive Independent Director
Fei Luo, Chairman, CEO, Chairman of Nomination Committee and Member of Remuneration Committee
Qizhang Zhang, Director of Marketing-Biostime Business Unit, Director of Corporate Innovation Marketing Center
Jiahua Peng, General Manager - Southern District of BNC business department of the Group
Hui Zhu, Director of the public affairs department
Lesheng Xu, Strategy and Devel. Director
Dingping Zhu, Senior Sales Director
Oliver Horn, Managing Director of Swisse
Wenhui Zhang, Non-Executive Director
Baichun Xiao, Non-Executive Independent Director
Li Zhao, General Manager - Sales and Marketing
Wee Tan, Non-Executive Independent Director
Qingjuan Kong, COO and Executive Director
Shifeng Liu, Director of the brand project department of ?ADIMIL?
Radek Sali, Executive Director
Haigang Tang, Supply Chain Director
Wenhui Cao, Chief Fin. Officer
Sa Xu, Director of the research and development department
Tak Wong, Joint Company Secretary
Charles Ravel, Managing Director - BNC International division
George Livery, Director of Strategy and Corporate Development and Company Secretary of Swisse
Yun Luo, Non-Executive Director
Elise Morris, Director of People & Culture of Swisse
Xiong Wu, Non-Executive Director
Tom Coleman, CFO of Swisse

Stock Performance Indicators

Did you try this?

Run Efficient Frontier Now
   

Efficient Frontier

Plot and analyze your portfolio and positions against risk-return landscape of the market.
All  Next Launch Efficient Frontier

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Health and Bristol Myers Squibb. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. macroaxis watchlist is based on self-learning algorithm to remember stocks you like.